Vaxcyte, Inc. (PCVX)
NASDAQ · Healthcare
Vaxcyte, Inc. Net Income 2020–2025
Vaxcyte, Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Vaxcyte, Inc. net income for the quarter ending March 31, 2026 was -320.6 M, a 127.85% increase year-over-year.
- Vaxcyte, Inc. net income for the twelve months ending March 31, 2026 was -946.5 M.
- Vaxcyte, Inc. annual net income for 2025 was -766.6 M, a 65.25% increase from 2024.
- Vaxcyte, Inc. annual net income for 2024 was -463.9 M, a 15.33% increase from 2023.
- Vaxcyte, Inc. annual net income for 2023 was -402.3 M, a 80.00% increase from 2022.
- Vaxcyte, Inc. annual net income for 2022 was -223.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vaxcyte, Inc. Net Income — FAQ
Vaxcyte, Inc. (PCVX) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Vaxcyte, Inc.'s net income?
Vaxcyte, Inc. (PCVX) reported net income of -$767M for fiscal 2025.
Where can I see PCVX's net income history?
The chart and table above show Vaxcyte, Inc.'s net income by year and by quarter, including the growth rate.